Roche is a global pioneer in pharmaceuticals and diagnostics focused on advancing science to improve people’s lives. The combined strengths of pharmaceuticals and diagnostics under one roof have made Roche the leader in personalised healthcare – a strategy that aims to fit the right treatment to each patient in the best way possible. Roche is the world’s largest biotech company, with truly differentiated medicines in oncology, immunology, infectious diseases, ophthalmology and diseases of the central nervous system. Roche is also the world leader in in vitro diagnostics and tissue-based cancer diagnostics, and a frontrunner in diabetes management. Founded in 1896, Roche continues to search for better ways to prevent, diagnose and treat diseases and make a sustainable contribution to society. The company also aims to improve patient access to medical innovations by working with all relevant stakeholders. Thirty medicines developed by Roche are included in the World Health Organization Model Lists of Essential Medicines, among them life-saving antibiotics, antimalarials and cancer medicines. Roche has been recognised as the Group Leader in sustainability within the Pharmaceuticals, Biotechnology & Life Sciences Industry ten years in a row by the Dow Jones Sustainability Indices (DJSI). For more information, please visit https://careers.roche.com Read our community guidelines here: https://www.roche.com/some-guidelines.htm #Roche #Biotechnology #Pharmaceuticals #Diagnostics #Healthcare #PersonalisedHealthcare #GreatPlaceToWork #Innovation
Unlock the market timeline & signal feed
1,109 signals in the last 90 days.
The order this company entered each market — oldest to newest
16 active postings
300 active postings
Sign up to see the full signal feed
How Roche's international expansion compares to its competitors
RocheYouBars show relative size across the companies compared.
Columns5| Company | Markets | New markets | Momentum | Activity | Expansion score |
|---|---|---|---|---|---|
 RocheYou | 70 | 0 | +16% | 1.0k | 37 |
(高级)治疗领域专员 - 免疫治疗领域
View postingQingdao, Shandong, China · today
治疗领域专员
View postingChengdu, Sichuan, China · yesterday
Business Finance Senior Partner
View postingSabana Norte, San Jose, Costa Rica · yesterday
Fighting disease and the status quo – to turn breakthrough science into tangible impact.Next week, the global biotech community gathers at #BIO2026 in San Diego. At Roche, we believe that no single company can solve the world's most complex and pressing healthcare challenges alone.We are headed to the San Diego Convention Centre to connect with innovators, pioneers, existing and future partners across neurology, oncology, CVRM, AI, digital health and beyond. Our goal? To build and foster partner ...
Ended
Will you be at Digital Biomarkers in Clinical Trials Summit in Basel June 23?I’ll be at Roche booth #1 and would welcome the opportunity to discuss the evolving role of digital biomarkers in Parkinson’s disease research and how they may complement established clinical outcome assessments.We are sharing a white paper that outlines learnings from a Phase II study evaluating a digital biomarker approach for remote motor assessment. The paper discusses patient adherence, user experience and prelimin ...
Ended
The latest for you: Roche’s highlights from #EHA2026
EndedInnovent Biologics presented preclinical data for IBI3055, a novel anti-CD19/BCMA/CD3 trispecific antibody, at the Immune Resetting Summit, demonstrating effective B-cell and plasma cell depletion for autoimmune diseases.
KMDIA International Exchange Committee launches Medi-Talk webinars and open innovation platform to support Korean medical device companies' US market entry and startup development through networking with multinational firms.
Roche China launched expanded indication for Xofluza dry suspension for children aged 1+, offering single-dose flu treatment with strawberry flavor and precise dosing.
Unlock verified emails & direct dials
Free · No credit card needed
Quick answers about Roche's business, markets, and growth signals.
Pubrio glocalizes business, people, and intent data from 50+ local sources into one global graph, giving AI and revenue teams full‑market visibility.
© 2026 Pubrio. All rights reserved.
